A phase II study to evaluate the efficacy and safety of oral fludarabine phosphate in combination with mitoxantrone as first-line treatment in follicular NHL.

Trial Profile

A phase II study to evaluate the efficacy and safety of oral fludarabine phosphate in combination with mitoxantrone as first-line treatment in follicular NHL.

Completed
Phase of Trial: Phase II

Latest Information Update: 24 Aug 2013

At a glance

  • Drugs Fludarabine; Mitoxantrone
  • Indications Follicular lymphoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 28 Jul 2010 Genzyme added as trial sponsor and affiliate as reported by ClinicalTrials.gov.
    • 14 Jul 2009 Actual patient numbers changed from 60 to 62 as reported by ClinicalTrials.gov.
    • 27 Oct 2008 Actual start date changed from Jul 2004 to Jun 2004 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top